🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareThe "Ozempic face" phenomenon — adipose redistribution or volume loss? Page 3

The "Ozempic face" phenomenon — adipose redistribution or volume loss?

Dr.Martinez Wed, May 6, 2026 at 9:00 AM 14 replies 747 viewsPage 3 of 3
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
May 13, 2026 at 7:03 AM#11
Dr.SurgeonPGH said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Last edited: May 13, 2026 at 10:03 AM
8 6JenMemphis, pat_auckland, Dr.GastroMayo and 5 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
May 14, 2026 at 2:20 PM#12
mona_PHX said:
The mechanism that matters here is not stomach emptying, it is central.

That reframing is the part I needed. I will report back once I have actually tried it.

Last edited: May 14, 2026 at 4:20 PM
9 7emily_PDX, Dr.SleepRoch, laura_annarbor and 6 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
May 15, 2026 at 9:36 PM#13
Dr.SurgeonPGH said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

10 8denise_HTX, raj_cambridge, ingrid_STO and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
May 17, 2026 at 4:52 AM#14

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

11 9TirzTom, TrialTracker_MD, JennaRN and 8 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 18, 2026 at 12:07 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. No action needed from anybody.

12 10PurityPaulOR, MaxMetOK, MounjBrad and 9 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register